Siriraj Hospital, Bangkok, Thailand.
AIDS Patient Care STDS. 2010 Feb;24(2):127-31. doi: 10.1089/apc.2009.0224.
Characterizing intraregional differences in current pediatric HIV care and treatment in Asia can guide the development of clinical practice guidelines and improve the understanding of local resource availability. The Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia) Pediatric Program is a collaboration of clinics and referral hospitals studying pediatric HIV outcomes in the region. A Web-based survey to characterize clinical management practices and monitoring resources was developed and distributed to 20 sites in January 2008. Seventeen (85%) sites from 6 countries responded through April 2008; 14 (82%) were hospital-based and 16 (94%) were public facilities. Of 4050 HIV-infected children under care, 3606 (89%) were on antiretroviral treatment; 80% were on their first mono-, dual-, or triple-drug regimen and 74% were on nevirapine- or efavirenz-based regimens. Fifteen (88%) sites had consistent access to polymerase chain reaction (PCR) testing for infant diagnosis. All sites had access to CD4 testing, with 13 (76%) routinely monitoring patients every 3-6 months; 7 (41%) sites monitored viral load at 6- to 12-month intervals. Although there is some variation in clinical practices, high levels of treatment and monitoring resources were available at these sites. The availability of PCR for early infant diagnosis positions them to implement recent WHO recommendations to treat HIV-infected children younger than 1 year of age. This information will be used to develop future research and programs to support children with HIV in Asia.
描述亚洲当前儿科艾滋病护理和治疗的区域内差异,可以为临床实践指南的制定提供指导,并增进对当地资源可利用性的了解。亚洲治疗研究、教育和艾滋病培训(TREAT Asia)儿科项目是一个合作项目,参与项目的有研究该地区儿科艾滋病结局的诊所和转诊医院。我们开发了一个基于网络的调查,用以描述临床管理做法和监测资源,并于 2008 年 1 月分发给 20 个地点。2008 年 4 月前,来自 6 个国家的 17 个(85%)地点做出了回应;其中 14 个(82%)为医院,16 个(94%)为公立机构。在接受护理的 4050 名感染艾滋病毒的儿童中,3606 名(89%)正在接受抗逆转录病毒治疗;80%的儿童正在使用单一、双重或三重药物方案,74%的儿童正在使用奈韦拉平或依非韦伦方案。15 个(88%)地点可以持续进行婴儿诊断用聚合酶链反应(PCR)检测。所有地点都可以进行 CD4 检测,其中 13 个(76%)每 3-6 个月定期监测患者;7 个(41%)地点每 6-12 个月监测一次病毒载量。虽然临床实践存在一些差异,但这些地点都拥有较高水平的治疗和监测资源。这些地点可以利用 PCR 进行早期婴儿诊断,以实施世界卫生组织最近提出的将年龄在 1 岁以下的感染艾滋病毒的儿童纳入治疗范围的建议。这些信息将用于制定未来的研究和计划,以支持亚洲的艾滋病毒儿童。